STRATEC Biomedical AG (SBSG)

Currency in EUR
23.000
+0.100(+0.44%)
Closed·
SBSG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.70023.300
52 wk Range
19.58037.400
Key Statistics
Bid/Ask
22.75 / 22.95
Prev. Close
22.9
Open
23.3
Day's Range
22.7-23.3
52 wk Range
19.58-37.4
Volume
5.23K
Average Volume (3m)
16.04K
1-Year Change
-31.7507%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBSG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
32.220
Upside
+40.09%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

STRATEC Biomedical AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

STRATEC Biomedical AG Company Profile

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Employees
1420
Market
Germany

Compare SBSG to Peers and Sector

Metrics to compare
SBSG
Peers
Sector
Relationship
P/E Ratio
18.1x20.9x−0.6x
PEG Ratio
0.80−0.280.00
Price/Book
1.2x1.6x2.6x
Price / LTM Sales
1.1x2.0x3.4x
Upside (Analyst Target)
26.6%47.1%42.0%
Fair Value Upside
Unlock12.0%5.0%Unlock

Analyst Ratings

5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 32.220
(+40.09% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Deutsche Bank
Hold27.00+17.39%30.00MaintainNov 12, 2025
Kepler Cheuvreux
Buy29.00+26.09%34.00MaintainNov 10, 2025
Berenberg
Buy46.00+100.00%51.00MaintainNov 03, 2025
Deutsche Bank
Hold30.00+30.43%33.00MaintainOct 23, 2025
Berenberg
Buy51.00+121.74%50.00MaintainAug 22, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.26%
Dividend Yield
2.61%
Industry Median 1.79%
Annualized payout
0.60
Paid annually
5-Years Growth
-6.51%
Growth Streak

Earnings

Latest Release
Nov 07, 2025
EPS / Forecast
0.13 / --
Revenue / Forecast
57.00M / --
EPS Revisions
Last 90 days

SBSG Income Statement

People Also Watch

40.700
FIEG
-0.61%
16.2600
ILM1k
+6.00%
7.94
TFFP
-1.00%
84.40
ADNGk
-1.75%
20.850
GFTG
-1.42%

FAQ

What Is the STRATEC Biomedical (SBSG) Stock Price Today?

The STRATEC Biomedical stock price today is 23.000

What Stock Exchange Does STRATEC Biomedical Trade On?

STRATEC Biomedical is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for STRATEC Biomedical?

The stock symbol for STRATEC Biomedical is "SBSG."

Does STRATEC Biomedical Pay Dividends? What’s The Current Dividend Yield?

The STRATEC Biomedical dividend yield is 2.61%.

What Is the STRATEC Biomedical Market Cap?

As of today, STRATEC Biomedical market cap is 279.59M.

What Is STRATEC Biomedical's Earnings Per Share (TTM)?

The STRATEC Biomedical EPS (TTM) is 1.26.

When Is the Next STRATEC Biomedical Earnings Date?

STRATEC Biomedical will release its next earnings report on Mar 26, 2026.

From a Technical Analysis Perspective, Is SBSG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has STRATEC Biomedical Stock Split?

STRATEC Biomedical has split 1 times.

How Many Employees Does STRATEC Biomedical Have?

STRATEC Biomedical has 1420 employees.

What is the current trading status of STRATEC Biomedical (SBSG)?

As of Jan 24, 2026, STRATEC Biomedical (SBSG) is trading at a price of 23.000, with a previous close of 22.900. The stock has fluctuated within a day range of 22.700 to 23.300, while its 52-week range spans from 19.580 to 37.400.

What Is STRATEC Biomedical (SBSG) Price Target According to Analysts?

The average 12-month price target for STRATEC Biomedical is EUR32.220, with a high estimate of EUR46 and a low estimate of EUR27. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +40.09% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.